Literature DB >> 17574289

Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domain.

Mudit Kakar1, James R Davis, Steve E Kern, Carol S Lim.   

Abstract

Ligand regulated localization controllable protein constructs were optimized in this study. Several constructs were made from a classical nuclear export signal (HIV-rev, MAPKK, or progesterone receptor) in combination with a SV40 T-antigen type nuclear import signal. Different ligand binding domains (LBDs from glucocorticoid receptor or progesterone receptor) were also tested for their ability to impart control over localization of proteins. This study was designed to create constructs which are cytoplasmic in the absence of ligand and nuclear in the presence of ligand, and also to regulate the amount of protein translocating to the nucleus on ligand induction. The balance between the strengths of import and export signals was critical for overall localization of proteins. The amount of protein entering the nucleus was also affected by the dose of ligand (10-100 nM). However, the overall import characteristics were determined by the strengths of localization signals and the inherent localization properties of the LBD used. This study established that the amount of protein present in a particular compartment can be regulated by the use of localization signals of various strengths. These optimized localization controllable protein constructs can be used to correct for diseases due to aberrant localization of proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574289      PMCID: PMC2041942          DOI: 10.1016/j.jconrel.2007.04.017

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  50 in total

Review 1.  The green fluorescent protein.

Authors:  R Y Tsien
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 2.  Nucleocytoplasmic transport: the soluble phase.

Authors:  I W Mattaj; L Englmeier
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  CRM1 is an export receptor for leucine-rich nuclear export signals.

Authors:  M Fornerod; M Ohno; M Yoshida; I W Mattaj
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

4.  Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay.

Authors:  H P Bogerd; R A Fridell; R E Benson; J Hua; B R Cullen
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

Review 5.  Nucleocytoplasmic transport: signals, mechanisms and regulation.

Authors:  E A Nigg
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

6.  Nuclear localization and export signals of the human aryl hydrocarbon receptor.

Authors:  T Ikuta; H Eguchi; T Tachibana; Y Yoneda; K Kawajiri
Journal:  J Biol Chem       Date:  1998-01-30       Impact factor: 5.157

7.  Kinetic characterization of the human retinoblastoma protein bipartite nuclear localization sequence (NLS) in vivo and in vitro. A comparison with the SV40 large T-antigen NLS.

Authors:  A Efthymiadis; H Shao; S Hübner; D A Jans
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

Review 8.  Nuclear import of protein kinases and cyclins.

Authors:  T Boulikas
Journal:  J Cell Biochem       Date:  1996-01       Impact factor: 4.429

9.  Nucleosome assembly activity and intracellular localization of human CAF-1 changes during the cell division cycle.

Authors:  K Marheineke; T Krude
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

10.  Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor.

Authors:  H Htun; L T Holth; D Walker; J R Davie; G L Hager
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

View more
  14 in total

1.  The nuclear translocation assay for intracellular protein-protein interactions and its application to the Bcr coiled-coil domain.

Authors:  Andrew S Dixon; Carol S Lim
Journal:  Biotechniques       Date:  2010-07       Impact factor: 1.993

2.  Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switch.

Authors:  Mudit Kakar; Amy B Cadwallader; James R Davis; Carol S Lim
Journal:  Pharm Res       Date:  2007-06-13       Impact factor: 4.200

3.  Disruption of Bcr-Abl coiled coil oligomerization by design.

Authors:  Andrew S Dixon; Scott S Pendley; Benjamin J Bruno; David W Woessner; Adrian A Shimpi; Thomas E Cheatham; Carol S Lim
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

4.  Changing the subcellular location of the oncoprotein Bcr-Abl using rationally designed capture motifs.

Authors:  Andrew S Dixon; Jonathan E Constance; Tomoyuki Tanaka; Terence H Rabbitts; Carol S Lim
Journal:  Pharm Res       Date:  2011-12-20       Impact factor: 4.200

5.  Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocation.

Authors:  Amy B Cadwallader; Douglas E Rollins; Carol S Lim
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 6.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

7.  Selective targeting of c-Abl via a cryptic mitochondrial targeting signal activated by cellular redox status in leukemic and breast cancer cells.

Authors:  Jonathan E Constance; Samuel D Despres; Akemi Nishida; Carol S Lim
Journal:  Pharm Res       Date:  2012-05-02       Impact factor: 4.200

8.  Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosis.

Authors:  Andrew S Dixon; Mudit Kakar; Korbinian M H Schneider; Jonathan E Constance; Blake C Paullin; Carol S Lim
Journal:  J Control Release       Date:  2009-07-01       Impact factor: 9.776

9.  Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.

Authors:  James R Davis; Mohanad Mossalam; Carol S Lim
Journal:  Mol Pharm       Date:  2013-03-01       Impact factor: 4.939

10.  Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fraction.

Authors:  James R Davis; Mohanad Mossalam; Carol S Lim
Journal:  Pharm Res       Date:  2012-08-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.